首页> 外文期刊>BMC Cardiovascular Disorders >Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes
【24h】

Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes

机译:可溶性VEGF受体同种型的血浆水平,循环粘液和VEGF系统SNP作为急性冠状动脉综合征患者的预后生物标志物

获取原文
       

摘要

Development of collateral circulation in coronary artery disease is cardio-protective. A key process in forming new blood vessels is attraction to occluded arteries of monocytes with their subsequent activation as macrophages. In patients from a prospectively recruited post-acute coronary syndromes cohort we investigated the prognostic performance of three products of activated macrophages, soluble vascular endothelial growth factor (VEGF) receptors (sFlt-1 and sKDR) and pterins, alongside genetic variants in VEGF receptor genes, VEGFR-1 and VEGFR-2. Baseline levels of sFlt-1 (VEGFR1), sKDR (VEGFR2) and pterins were measured in plasma samples from subgroups (n?=?513; 211; 144, respectively) of the Coronary Disease Cohort Study (CDCS, n?=?2067). DNA samples from the cohort were genotyped for polymorphisms from the VEGFR-1 gene SNPs (rs748252 n?=?2027, rs9513070 n?=?2048) and VEGFR-2 gene SNPs (rs2071559 n?=?2050, rs2305948 n?=?2066, rs1870377 n?=?2042). At baseline, levels of sFlt-1 were significantly correlated with age, alcohol consumption, NTproBNP, BNP and other covariates relevant to cardiovascular pathophysiology. Total neopterin levels were associated with alcohol consumption at baseline. 7,8 dihydroneopterin was associated with BMI. The A allele of VEGFR-2 variant rs1870377 was associated with higher plasma sFlt-1 and lower levels of sKDR at baseline. Baseline plasma sFlt-1 was univariately associated with all cause mortality with (p?
机译:冠状动脉疾病中的抵押血液循环的发展是有氧运动的。形成新血管的关键方法是将单核细胞动脉与后续激活作为巨噬细胞的吸引力。在患者中,患有前瞻性急性冠状动脉综合征群组中,我们研究了VEGF受体基因中的三种活化巨噬细胞,可溶性血管内皮生长因子(VEGF)受体(SFLT-1和SKDR)和Pterins的预后性能,以及VEGF受体基因的遗传变异,VEGFR-1和VEGFR-2。在亚组的血浆样品中测量SFLT-1(VEGFR1),SKDR(VEGFR2)和粘膜的基线水平(n?=Δ513; 211; 144分别)冠状病队列队列研究(CDC,N?= 2067 )。来自群组的DNA样品是来自VEGFR-1基因SNP的多态性的基因分型(RS748252 N?= 2027,RS9513070 N?=?2048)和VEGFR-2基因SNP(RS2071559 N?= 2050,RS2305948 N?=? 2066,RS1870377 N?=?2042)。在基线时,SFLT-1的水平与与心血管病理生理学相关的年龄,酒精消费,NTPROBNP,BNP和其他协变量显着相关。 Neopterin水平总与基线的醇消耗相关。 7,8二氢酮网与BMI有关。 VEGFR-2变体RS1870377的等位基因与基线的较高血浆SFLT-1和低水平的SKDR相关联。基线血浆SFLT-1与所有原因死亡率无关(P?<0.001),并且在COX的比例危险中,SFLT-1和粘膜均与成立的预测因子无关(P?<β027)。急性冠状动脉综合征患者中,SFLT-1和Pterins可能具有急性冠状动脉综合征患者的预后生物标志物。 VEGF系统基因的遗传标记需要进一步调查这些患者VEGF系统组分水平的标记。澳大利亚新西兰临床试验登记处。 ACTRN12605000431628。 2005年9月16日,回顾性注册。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号